Spectrum of beta-thalassemia Mutations in Iran, an Update

被引:0
作者
Bazi, Ali [1 ]
Miri-Moghaddam, Ebrahim [2 ]
机构
[1] Zabol Univ Med Sci, Fac Allied Med Sci, Zabol, Iran
[2] Zahedan Univ Med Sci, Dept Genet, Fac Med, Genet Noncommunicable Dis Res Ctr, Zahedan, Iran
关键词
beta-thalassemia major; genetic modifiers; Iran; mutation;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
beta-thalassemia major (beta -TM) is the most common thalassemia severe phenotype among Iranians. In recent years, molecular understanding of pathogenesis of beta -TM has provided a great opportunity regarding diagnostic issues. Creating comprehensive molecular databases provides highly sensitive diagnostic tools for beta -TM and effective prenatal diagnosis (PND) molecular screening tests. Despite a large body of research on molecular basis of beta -TM, there are few review papers that consider a general view on the distribution of beta -TM mutations in Iran. In the current review, common genetic defects identified in Iranian beta -TM patients since 2005 to 2014 have been described. In addition, the prevalences and distributional trends of recognized mutations were discussed. It was found that IVSII-1 (G>A) and IVSI-5 (G>C) were by far the most frequent mutations detected in Iranian patients. Other common reported mutations included FSC 8/9 (+G), IVS I-110 (G>A), FSC 36/37 (-T), IVSI-1 (G>A), IVSI (-25bp), and codon 44 (-C). In conclusion, it was found that molecular profile of beta -TM is highly variable among different Iranian populations; in particular, it seems that ethnicity and intra-migration can be most important participating factors in controlling distributional patterns.
引用
收藏
页码:190 / 202
页数:13
相关论文
共 53 条
[1]   MOLECULAR BASIS OF β-THALASSEMIA IN THE WESTERN PROVINCE OF SAUDI ARABIA: IDENTIFICATION OF RARE β-THALASSEMIA MUTATIONS [J].
Abuzenadah, Adel M. ;
Hussein, Ibtessam M. Ramzi ;
Damanhouri, Ghazi A. ;
A-Sayes, Faten M. ;
Gari, Mamdouh A. ;
Chaudhary, Adeel G. ;
Zaher, Galila F. ;
Al-Attas, Asma'a ;
Al-Qahtani, Mohammad H. .
HEMOGLOBIN, 2011, 35 (04) :346-357
[2]   MOLECULAR BASIS OF THALASSEMIA INTERMEDIA IN IRAN [J].
Akbari, Mohammad T. ;
Izadi, Pantea ;
Izadyar, Mina ;
Kyriacou, Kyriacou ;
Kleanthous, Marina .
HEMOGLOBIN, 2008, 32 (05) :462-470
[3]   A comprehensive molecular characterization of beta thalassemia in a highly heterogeneous population [J].
Akhavan-Niaki, Haleh ;
Derakhshandeh-Peykar, Poupak ;
Banihashemi, Ali ;
Mostafazadeh, Amrollah ;
Asghari, Beheshteh ;
Ahmadifard, Mohammad-Reza ;
Azizi, Mandana ;
Youssefi, Ali ;
Elmi, Maryam Mitra .
BLOOD CELLS MOLECULES AND DISEASES, 2011, 47 (01) :29-32
[4]  
Al-Azzawie H, 2013, CURR RES MICROBIOL B, V1, P160
[5]  
Ansari SH, 2011, INT J MOL EPIDEMIOL, V2, P403
[6]   Molecular characterization of β-thalassemia intermedia: a report from Iran [J].
Arab, Aida ;
Karimipoor, Morteza ;
Rajabi, Ali ;
Hamid, Mohammad ;
Arjmandi, Sedeigheh ;
Zeinali, Sirous .
MOLECULAR BIOLOGY REPORTS, 2011, 38 (07) :4321-4326
[7]   MOLECULAR BASIS OF β-THALASSEMIA IN THE UNITED ARAB EMIRATES [J].
Baysal, Erol .
HEMOGLOBIN, 2011, 35 (5-6) :581-588
[8]  
Dehghanifard Ali, 2013, Int J Hematol Oncol Stem Cell Res, V7, P17
[9]   Distribution of β-thalassemia mutations in the northern provinces of Iran [J].
Derakhshandeh-Peykar, Pupak ;
Akhavan-Niaki, Haleh ;
Tamaddoni, Ahmad ;
Ghawidel-Parsa, Shohreh ;
Naieni, Kourosh Holakouie ;
Rahmani, Manijeh ;
Babrzadeh, Farbod ;
Dilmaghani-Zadeh, Mohammad ;
Farhud, Dariush Daneshvar .
HEMOGLOBIN, 2007, 31 (03) :351-356
[10]  
Eshghi P., 2013, SCI J IRAN BLOOD TRA, V9, P406